BioLife Sciences Inc. (BLFE)
USD 0.0
(9900.0%)
USD 0.0
(9900.0%)
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2022 | - USD | 0.0% |
| 2021 | - USD | 100.0% |
| 2020 | -1.24 Million USD | -823.67% |
| 2019 | 171.86 Thousand USD | 506.48% |
| 2018 | -42.28 Thousand USD | 87.15% |
| 2017 | -329.13 Thousand USD | -2533.04% |
| 2016 | -12.5 Thousand USD | 40.93% |
| 2015 | -21.15 Thousand USD | 0.0% |
| 2007 | -1.08 Million USD | 2237.75% |
| 2006 | 183.73 Thousand USD | 112.71% |
| 2005 | -526.81 Thousand USD | -2381.21% |
| 2004 | -17.86 Thousand USD | 0.0% |
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2023 Q2 | - USD | 0.0% |
| 2023 Q1 | - USD | 0.0% |
| 2023 Q3 | - USD | 0.0% |
| 2022 Q1 | -9.24 USD | 0.0% |
| 2022 Q4 | - USD | 0.0% |
| 2022 FY | - USD | 0.0% |
| 2022 Q3 | - USD | 0.0% |
| 2021 FY | - USD | 100.0% |
| 2021 Q2 | -126.23 Thousand USD | -120.3% |
| 2021 Q1 | -57.3 Thousand USD | 0.0% |
| 2021 Q3 | -134.76 Thousand USD | -6.76% |
| 2020 FY | - USD | -823.67% |
| 2019 FY | - USD | 506.48% |
| 2018 FY | - USD | 87.15% |
| 2017 FY | - USD | -2533.04% |
| 2016 FY | - USD | 40.93% |
| 2015 FY | - USD | 0.0% |
| 2008 Q2 | 447 Thousand USD | 368.01% |
| 2008 Q1 | 95.51 Thousand USD | -84.66% |
| 2007 Q2 | 645.8 Thousand USD | 151.82% |
| 2007 Q4 | 622.65 Thousand USD | 109.38% |
| 2007 Q1 | 256.45 Thousand USD | 155.8% |
| 2007 FY | - USD | 2237.75% |
| 2007 Q3 | 297.38 Thousand USD | -53.95% |
| 2006 Q2 | 1.17 Million USD | 473.26% |
| 2006 FY | - USD | 112.71% |
| 2006 Q4 | -459.61 Thousand USD | -155.86% |
| 2006 Q1 | -315.78 Thousand USD | 22.44% |
| 2006 Q3 | 822.77 Thousand USD | -30.2% |
| 2005 Q1 | -3500.00 USD | 0.0% |
| 2005 Q2 | -50.33 Thousand USD | -1338.0% |
| 2005 Q3 | -77.23 Thousand USD | -53.46% |
| 2005 FY | - USD | -2381.21% |
| 2005 Q4 | -407.13 Thousand USD | -427.14% |
| 2004 FY | - USD | 0.0% |
| Name | EBITDA | EBITDA Difference |
|---|---|---|
| American Medical Technologies Inc. | -963.95 Thousand USD | 100.0% |
| Ansell Limited | 209.86 Million USD | 100.0% |
| Ansell Limited | 206.3 Million USD | 100.0% |
| BG Medicine, Inc. | - USD | NaN% |
| Biotage AB (publ) | 42.83 Million USD | 100.0% |
| CB Scientific, Inc. | -1.62 Million USD | 100.0% |
| Psykey, Inc. | -1.29 Million USD | 100.0% |
| ConvaTec Group Plc | 455.5 Million USD | 100.0% |
| ConvaTec Group Plc | 455.5 Million USD | 100.0% |
| Encision Inc. | -544.19 Thousand USD | 100.0% |
| Golden Valley Development, Inc | -141.81 Thousand USD | 100.0% |
| Hear AtLast Holdings, Inc. | -109.93 Thousand USD | 100.0% |
| Innovative MedTech Inc. | -7.67 Million USD | 100.0% |
| LifePoint, Inc. | -14.2 Million USD | 100.0% |
| Medite Cancer Diagnostics, Inc. | -6.18 Million USD | 100.0% |
| Paradigm Medical Industries, Inc. | -325 Thousand USD | 100.0% |
| QuantRx Biomedical Corporation | - USD | NaN% |
| Remedent, Inc. | -215.23 Thousand USD | 100.0% |
| Reflect Scientific, Inc. | -405.78 Thousand USD | 100.0% |
| SmileDirectClub, Inc. | -186.13 Million USD | 100.0% |
| Sector 10, Inc. | - USD | NaN% |
| Shandong Weigao Group Medical Polymer Company Limited | 447.82 Million USD | 100.0% |
| SheerVision, Inc. | -110.53 Thousand USD | 100.0% |
| United Health Products, Inc. | -2.5 Million USD | 100.0% |
| Vasamed, Inc. | -4.57 Million USD | 100.0% |
| Wearable Health Solutions, Inc. | -2.26 Million USD | 100.0% |
| Yubo International Biotech Limited | -1.17 Million USD | 100.0% |